#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	886	CRP	633	633	99.53	CRP.l6.c30.ctg.1	1296	36.6	0	.	p	.	0	K29T	NONSYN	85	87	AAG	404	406	ACG	49;51;51	A;C;G	48;51;51	.	CRP;CRP is a global regulator that represses MdtEF multidrug efflux pump expression.
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	179	3372	Escherichia_coli_EF_Tu	1185	1174	99.66	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1174	131.4	1	SNP	p	L121Q	0	.	.	361	363	CTG	357	359	CTG	148;148;146	C;T;G	147;144;145	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:L121Q:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	179	3372	Escherichia_coli_EF_Tu	1185	1174	99.66	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1174	131.4	1	SNP	p	Q125K	0	.	.	373	375	CAG	369	371	CAG	149;146;145	C,T;A;G	148,1;145;145	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Q125K:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	179	3372	Escherichia_coli_EF_Tu	1185	1174	99.66	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1174	131.4	1	SNP	p	Q125R	0	.	.	373	375	CAG	369	371	CAG	149;146;145	C,T;A;G	148,1;145;145	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Q125R:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	179	3372	Escherichia_coli_EF_Tu	1185	1174	99.66	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1174	131.4	1	SNP	p	Q125E	0	.	.	373	375	CAG	369	371	CAG	149;146;145	C,T;A;G	148,1;145;145	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Q125E:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	179	3372	Escherichia_coli_EF_Tu	1185	1174	99.66	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1174	131.4	1	SNP	p	Y161C	0	.	.	481	483	TAC	477	479	TAC	175;176;177	T;A;C	173;176;177	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Y161C:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	179	3372	Escherichia_coli_EF_Tu	1185	1174	99.66	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1174	131.4	1	SNP	p	Y161D	0	.	.	481	483	TAC	477	479	TAC	175;176;177	T;A;C	173;176;177	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Y161D:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	179	3372	Escherichia_coli_EF_Tu	1185	1174	99.66	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1174	131.4	1	SNP	p	Y161N	0	.	.	481	483	TAC	477	479	TAC	175;176;177	T;A;C	173;176;177	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Y161N:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	179	3372	Escherichia_coli_EF_Tu	1185	1174	99.66	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1174	131.4	1	SNP	p	G317D	0	.	.	949	951	GGC	945	947	GGC	137;134;130	G;G;C,A	136;134;70,59	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:G317D:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	179	3372	Escherichia_coli_EF_Tu	1185	1174	99.66	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1174	131.4	1	SNP	p	A376V	0	.	.	1126	1128	GCA	1122	1124	GCA	95;94;94	G;C;A	89;84;94	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:A376V:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	179	3372	Escherichia_coli_EF_Tu	1185	1174	99.66	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1174	131.4	1	SNP	p	A376S	0	.	.	1126	1128	GCA	1122	1124	GCA	95;94;94	G;C;A	89;84;94	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:A376S:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	179	3372	Escherichia_coli_EF_Tu	1185	1174	99.66	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1174	131.4	1	SNP	p	E379K	0	.	.	1135	1137	GAA	1131	1133	GAA	85;86;86	G;A;A	82;86;85	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:E379K:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	179	3372	Escherichia_coli_EF_Tu	1185	1174	99.66	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1174	131.4	0	HET	.	.	.	T135C	.	135	135	T	131	131	T	102	T,C	51,36	.	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	179	3372	Escherichia_coli_EF_Tu	1185	1174	99.66	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1174	131.4	0	HET	.	.	.	C216T	.	216	216	C	212	212	C	135	C,T	77,57	.	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	1	1	539	1472	Escherichia_coli_mutant_1	1359	1359	99.85	Escherichia_coli_mutant_1.l15.c4.ctg.1	1979	39.8	1	SNP	p	E448K	1	E448K	NONSYN	1342	1344	GAA	1660	1662	AAA	30;28;28	A;A;A	30;28;28	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666:1:1:E448K:.:Mutations to the active importer GlpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant GlpT conferring resistance to fosfomycin
Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	1	1	27	1626	Escherichia_coli_mutant	1392	1392	99.43	Escherichia_coli_mutant.l15.c17.ctg.1	1925	45.0	1	SNP	p	E350Q	0	.	.	1048	1050	GAA	1363	1365	GAA	61;60;59	G;A;A	61;60;59	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667:1:1:E350Q:.:Mutations to the active importer UhpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant UhpT conferring resistance to fosfomycin
H_NS.3000676.NC_002695.1737553_1737967.218	H_NS.3000676.NC_002695.1737553_1737967.218	1	0	27	446	H_NS	414	414	99.03	H_NS.l6.c4.ctg.1	1043	22.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	H-NS;H-NS is a histone-like protein involved in global gene regulation in Gram-negative bacteria. It is a repressor of the membrane fusion protein genes acrE, mdtE, and emrK as well as nearby genes of many RND-type multidrug exporters.
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4346	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	846	137.8	0	.	n	.	0	T1041G	SNP	1041	1041	T	16	16	G	189	G	145	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4346	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	846	137.8	0	.	n	.	0	A1042T	SNP	1042	1042	A	17	17	T	195	T	151	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4346	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	846	137.8	0	.	n	.	0	A1136G	SNP	1136	1136	A	111	111	G	266	G	261	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4346	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	846	137.8	0	.	n	.	0	T1138C	SNP	1138	1138	T	113	113	C	252	C	251	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4346	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	846	137.8	0	.	n	.	0	T1142C	SNP	1142	1142	T	117	117	C	224	C	222	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4346	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	846	137.8	0	.	n	.	0	C1170T	SNP	1170	1170	C	145	145	T	199	T,C	198,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4346	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	846	137.8	0	.	n	.	0	T1220C	SNP	1220	1220	T	195	195	C	195	C	193	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4346	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	846	137.8	0	.	n	.	0	T1245C	SNP	1245	1245	T	220	220	C	164	C	164	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4346	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	846	137.8	0	.	n	.	0	G1253A	SNP	1253	1253	G	228	228	A	175	A	174	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4346	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	846	137.8	0	.	n	.	0	G1256A	SNP	1256	1256	G	231	231	A	183	A	182	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4346	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	846	137.8	0	.	n	.	0	C1258A	SNP	1258	1258	C	233	233	A	181	A	180	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4346	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	846	137.8	0	.	n	.	0	G1266T	SNP	1266	1266	G	241	241	T	186	T	184	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4346	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	846	137.8	0	.	n	.	0	T1267C	SNP	1267	1267	T	242	242	C	187	C,T	185,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4346	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	846	137.8	0	.	n	.	0	T1275C	SNP	1275	1275	T	250	250	C	175	C,A	174,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4346	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	846	137.8	0	.	n	.	0	G1276A	SNP	1276	1276	G	251	251	A	181	A,G	178,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4346	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	846	137.8	0	.	n	.	0	A1281G	SNP	1281	1281	A	256	256	G	165	G	165	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4346	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	846	137.8	0	.	n	.	0	T1283C	SNP	1283	1283	T	258	258	C	167	C	164	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4346	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	846	137.8	0	.	n	.	0	G1288T	SNP	1288	1288	G	263	263	T	177	T	176	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4346	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	846	137.8	0	.	n	.	0	A1296G	SNP	1296	1296	A	271	271	G	223	G	222	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4346	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	846	137.8	0	.	n	.	0	T1299G	SNP	1299	1299	T	274	274	G	236	G	235	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4346	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	846	137.8	0	.	n	.	0	A1300T	SNP	1300	1300	A	275	275	T	242	T	238	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4346	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	846	137.8	0	.	n	.	0	C1356T	SNP	1356	1356	C	331	331	T	240	T	239	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4346	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	846	137.8	0	.	n	.	0	A1358G	SNP	1358	1358	A	333	333	G	229	G	227	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4346	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	846	137.8	0	.	n	.	0	T1368C	SNP	1368	1368	T	343	343	C	174	C	173	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4346	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	846	137.8	0	.	n	.	0	G1370A	SNP	1370	1370	G	345	345	A	160	A	160	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4346	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	846	137.8	0	.	n	.	0	C1406.	DEL	1406	1406	C	380	380	C	105	C	104	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4346	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	846	137.8	0	.	n	.	0	.1409C	INS	1409	1409	T	384	384	C	93	C	92	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4346	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	846	137.8	0	.	n	.	0	C1431A	SNP	1431	1431	C	406	406	A	20	A	20	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4346	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	846	137.8	0	.	n	.	0	C1432A	SNP	1432	1432	C	407	407	A	20	A	20	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4346	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	846	137.8	0	.	n	.	0	A1441G	SNP	1441	1441	A	416	416	G	17	G	17	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4346	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	846	137.8	0	.	n	.	0	T1464C	SNP	1464	1464	T	439	439	C	23	C	23	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4346	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	846	137.8	0	.	n	.	0	G1473T	SNP	1473	1473	G	448	448	T	91	T	91	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4346	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	846	137.8	0	.	n	.	0	A1475G	SNP	1475	1475	A	450	450	G	103	G	103	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4346	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	846	137.8	0	.	n	.	0	A1548T	SNP	1548	1548	A	523	523	T	94	T	94	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4346	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	846	137.8	1	SNP	n	C1194G	0	.	.	1194	1194	C	169	169	C	209	C	208	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252:0:0:C1194G:.:Point mutations in the helix 34 region of 16S rRNA of Pasteurella multocida can confer resistance to spectinomycin	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	4346	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	846	137.8	0	HET	.	.	.	C1040T	.	1040	1040	T	15	15	C	171	C,T	83,43	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	1280	PmrB_1	1092	1092	99.08	PmrB_1.l15.c4.ctg.1	1682	40.6	0	.	p	.	0	H2R	NONSYN	4	6	CAT	307	309	CGT	43;44;45	C;G;T	43;44;45	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	1280	PmrB_1	1092	1092	99.08	PmrB_1.l15.c4.ctg.1	1682	40.6	0	.	p	.	0	V30I	NONSYN	88	90	GTC	391	393	ATC	47;45;44	A;T;C	46;45;44	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	1280	PmrB_1	1092	1092	99.08	PmrB_1.l15.c4.ctg.1	1682	40.6	0	.	p	.	0	D283G	NONSYN	847	849	GAC	1150	1152	GGC	57;57;56	G;G;C	57;57;55	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1874	PmrC	1644	1644	99.15	PmrC.l6.c30.ctg.1	2126	47.1	0	.	p	.	0	R8S	NONSYN	22	24	AGA	256	258	AGC	27;26;26	A;G;C	27;26;26	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1874	PmrC	1644	1644	99.15	PmrC.l6.c30.ctg.1	2126	47.1	0	.	p	.	0	I142L	NONSYN	424	426	ATA	658	660	CTA	50;49;49	C;T;A	50;49;49	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1874	PmrC	1644	1644	99.15	PmrC.l6.c30.ctg.1	2126	47.1	0	.	p	.	0	R315Q	NONSYN	943	945	CGA	1177	1179	CAA	54;55;56	C;A;A	54;55;56	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1874	PmrC	1644	1644	99.15	PmrC.l6.c30.ctg.1	2126	47.1	0	.	p	.	0	D348G	NONSYN	1042	1044	GAT	1276	1278	GGT	66;66;65	G;G;T	66;66;64	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1874	PmrC	1644	1644	99.15	PmrC.l6.c30.ctg.1	2126	47.1	0	.	p	.	0	I538V	NONSYN	1612	1614	ATT	1846	1848	GTT	42;42;40	G;T;T	41;42;40	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	858	PmrE	1167	1167	96.83	PmrE.l15.c30.ctg.1	1727	26.5	0	.	p	.	0	A125E	NONSYN	373	375	GCA	670	672	GAA	32;31;31	G;A;A	32;31;31	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	858	PmrE	1167	1167	96.83	PmrE.l15.c30.ctg.1	1727	26.5	0	.	p	.	0	M185T	NONSYN	553	555	ATG	850	852	ACC	22;22;22	A;C;C	22;22;22	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	858	PmrE	1167	1167	96.83	PmrE.l15.c30.ctg.1	1727	26.5	0	.	p	.	0	S225T	NONSYN	673	675	TCC	970	972	ACT	16;17;15	A;C;T	16;17;15	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	858	PmrE	1167	1167	96.83	PmrE.l15.c30.ctg.1	1727	26.5	0	.	p	.	0	T355I	NONSYN	1063	1065	ACC	1360	1362	ATC	10;10;10	A;T;C	10;10;10	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrF.3003578.U00096.2367070_2368039.2115	PmrF.3003578.U00096.2367070_2368039.2115	1	0	27	1126	PmrF	969	969	99.38	PmrF.l6.c4.ctg.1	1625	36.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	PmrF;PmrF is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
TEM_124.3000986.AY327540.0_858.1398	TEM_124.3000986.AY327540.0_858.1398	1	0	512	78	TEM_1+	858	318	99.06	TEM_1+.l6.c30.ctg.1	318	4.0	0	.	p	.	0	V82I	NONSYN	244	246	GTT	203	205	ATT	3;3;2	A;T;T	3;3;2	.	TEM-124;TEM-124 is an extended-spectrum beta-lactamase found in Morganella morganii.
TEM_124.3000986.AY327540.0_858.1398	TEM_124.3000986.AY327540.0_858.1398	1	0	512	78	TEM_1+	858	318	99.06	TEM_1+.l6.c30.ctg.1	318	4.0	0	.	p	.	0	K102E	NONSYN	304	306	AAG	263	265	GAG	2;2;3	G;A;G	2;2;3	.	TEM-124;TEM-124 is an extended-spectrum beta-lactamase found in Morganella morganii.
TEM_124.3000986.AY327540.0_858.1398	TEM_124.3000986.AY327540.0_858.1398	1	0	512	78	TEM_1+	858	220	99.09	TEM_1+.l6.c30.ctg.2	220	4.7	0	.	p	.	0	T180M	NONSYN	538	540	ACG	102	104	ATG	4;4;4	A;T;G	4;4;4	.	TEM-124;TEM-124 is an extended-spectrum beta-lactamase found in Morganella morganii.
TEM_124.3000986.AY327540.0_858.1398	TEM_124.3000986.AY327540.0_858.1398	1	0	512	78	TEM_1+	858	220	99.09	TEM_1+.l6.c30.ctg.2	220	4.7	0	.	p	.	0	A182V	NONSYN	544	546	GCA	108	110	GTA	3;3;3	G;T;A	3;3;3	.	TEM-124;TEM-124 is an extended-spectrum beta-lactamase found in Morganella morganii.
aada1.manually_added_NC_007384_WP_001206315.1_4110458_4111246	aada1.manually_added_NC_007384_WP_001206315.1_4110458_4111246	1	0	27	1084	aad-	789	789	100.0	aad-.l15.c4.ctg.1	1417	40.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_007384.1 Shigella sonnei Ss046, complete genome
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	3124	acrD	3114	3114	99.07	acrD.l15.c30.ctg.1	3568	46.8	0	.	p	.	0	T85I	NONSYN	253	255	ACC	505	507	ATC	49;50;49	A;T;C	49;50;49	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	3124	acrD	3114	3114	99.07	acrD.l15.c30.ctg.1	3568	46.8	0	.	p	.	0	V416I	NONSYN	1246	1248	GTC	1498	1500	ATC	49;52;54	A,G;T;C	48,1;52;54	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	3124	acrD	3114	3114	99.07	acrD.l15.c30.ctg.1	3568	46.8	0	.	p	.	0	Q656K	NONSYN	1966	1968	CAA	2218	2220	AAG	38;38;38	A;A;G	37;38;36	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	1244	acrE	1158	1158	98.79	acrE.l15.c4.ctg.1	1663	40.0	0	.	p	.	0	A22V	NONSYN	64	66	GCC	329	331	GTC	13;13;13	G;T;C	13;13;13	.	acrE;AcrE is a membrane fusion protein, similar to AcrA.
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	1244	acrE	1158	1158	98.79	acrE.l15.c4.ctg.1	1663	40.0	0	.	p	.	0	S269C	NONSYN	805	807	AGC	1070	1072	TGC	70;70;74	T;G;C	70;70;74	.	acrE;AcrE is a membrane fusion protein, similar to AcrA.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	2890	acrF	3105	2598	98.04	acrF.l15.c4.ctg.1	2865	52.8	0	.	p	.	0	S46trunc	TRUNC	136	136	T	200	200	T	32	T	32	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	2890	acrF	3105	2598	98.04	acrF.l15.c4.ctg.1	2865	52.8	0	.	p	.	0	G148D	NONSYN	442	444	GGC	506	508	GAC	45;46;45	G;A;C	45;45;45	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	2890	acrF	3105	2598	98.04	acrF.l15.c4.ctg.1	2865	52.8	0	.	p	.	0	F240L	NONSYN	718	720	TTT	782	784	TTA	33;33;33	T;T;A	32;32;32	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	2890	acrF	3105	2598	98.04	acrF.l15.c4.ctg.1	2865	52.8	0	.	p	.	0	D301N	NONSYN	901	903	GAT	965	967	AAT	42;43;45	A;A;T	41;43;43	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	2890	acrF	3105	2598	98.04	acrF.l15.c4.ctg.1	2865	52.8	0	.	p	.	0	L563fs	FSHIFT	1687	1687	T	1752	1752	T	68	T	68	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrR.3003807.NC_000913.3.485760_486408.3575	acrR.3003807.NC_000913.3.485760_486408.3575	1	1	27	756	acrR_2	648	648	99.54	acrR_2.l15.c30.ctg.1	1200	33.5	1	SNP	p	R45C	0	.	.	133	135	CGC	397	399	CGC	59;59;60	C;G;C	59;59;60	acrR.3003807.NC_000913.3.485760_486408.3575:1:1:R45C:.:AcrR is a repressor of the AcrAB-TolC multidrug efflux complex. AcrR mutations result in high level antibiotic resistance. The mutations associated with this model are specific to E. coli.	Escherichia coli acrR mutants resulting in antibiotic resistance
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	702	acrS	663	663	98.64	acrS.l15.c30.ctg.1	1290	29.1	0	.	p	.	0	L34F	NONSYN	100	102	CTC	425	427	TTC	28;27;27	T;T;C	28;27;27	.	AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.;acrS
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	702	acrS	663	663	98.64	acrS.l15.c30.ctg.1	1290	29.1	0	.	p	.	0	E122G	NONSYN	364	366	GAG	689	691	GGG	55;55;55	G;G;G	55;55;55	.	AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.;acrS
adiY.3003828.NC_000913.3.4337167_4337929.3591	adiY.3003828.NC_000913.3.4337167_4337929.3591	1	0	539	1072	adiY	762	762	99.61	adiY.l15.c30.ctg.1	1258	45.2	0	.	p	.	0	V136L	NONSYN	406	408	GTT	703	705	CTT	61;60;61	C;T;T	61;60;61	.	adiY;adiY is a DNA-binding transcriptional activator of the adi system. Implicated in arginine-dependent acid resistance in Escherichia coli.
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	3306	alaS	2631	2631	98.86	alaS.l15.c4.ctg.1	3259	54.3	0	.	p	.	0	T618A	NONSYN	1852	1854	ACA	2124	2126	GCA	87;88;88	G;C;A	87;87;88	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	3306	alaS	2631	2631	98.86	alaS.l15.c4.ctg.1	3259	54.3	0	.	p	.	0	A705T	NONSYN	2113	2115	GCC	2385	2387	ACC	64;63;63	A;C;C	63;63;63	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	3306	alaS	2631	2631	98.86	alaS.l15.c4.ctg.1	3259	54.3	0	.	p	.	0	V808A	NONSYN	2422	2424	GTC	2694	2696	GCC	43;42;45	G;C;C	43;40;45	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1744	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2537	36.7	0	.	p	.	0	G37A	NONSYN	109	111	GGT	369	371	GCT	7;7;10	G;C;T	7;7;10	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1744	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2537	36.7	0	.	p	.	0	D77E	NONSYN	229	231	GAT	489	491	GAG	11;11;11	G;A;G	11;11;11	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1744	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2537	36.7	0	.	p	.	0	Y89C	NONSYN	265	267	TAC	525	527	TGC	20;21;26	T;G;C	20;21;26	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1744	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2537	36.7	0	.	p	.	0	I150V	NONSYN	448	450	ATT	708	710	GTT	41;42;42	G;T;T	41;42;42	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1744	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2537	36.7	0	.	p	.	0	R200H	NONSYN	598	600	CGC	858	860	CAC	43;43;44	C;A;C	43;43;44	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1744	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2537	36.7	0	.	p	.	0	T295M	NONSYN	883	885	ACG	1143	1145	ATG	52;53;55	A;T;G	50;52;54	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1744	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2537	36.7	0	.	p	.	0	H627R	NONSYN	1879	1881	CAC	2139	2141	CGC	37;38;38	C;G;C	37;38;37	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	740	bacA	822	822	98.54	bacA.l15.c17.ctg.1	1255	31.5	0	.	p	.	0	S221T	NONSYN	661	663	AGC	933	935	ACC	25;23;24	A;C;C	25;23;23	.	bacA;bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	740	bacA	822	822	98.54	bacA.l15.c17.ctg.1	1255	31.5	0	.	p	.	0	P225S	NONSYN	673	675	CCG	945	947	TCG	29;31;31	T;C;G	29;31;31	.	bacA;bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin
baeR.3000828.NC_007779.2166412_2167135.676	baeR.3000828.NC_007779.2166412_2167135.676	1	0	27	702	baeR	723	723	97.79	baeR.l15.c30.ctg.1	1208	31.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	baeR;BaeR is a response regulator that promotes the expression of MdtABC and AcrD efflux complexes.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1200	baeS	1404	1404	98.86	baeS.l6.c4.ctg.1	1866	33.9	0	.	p	.	0	Q376K	NONSYN	1126	1128	CAA	1344	1346	AAA	13;15;15	A;A;A	13;15;15	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1200	baeS	1404	1404	98.86	baeS.l6.c4.ctg.1	1866	33.9	0	.	p	.	0	G380E	NONSYN	1138	1140	GGG	1356	1358	GAG	14;16;17	G,A;A;G	12,1;15;16	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1200	baeS	1404	1404	98.86	baeS.l6.c4.ctg.1	1866	33.9	0	.	p	.	0	R382H	NONSYN	1144	1146	CGC	1362	1364	CAC	27;29;29	C;A;C	27;28;29	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1200	baeS	1404	1404	98.86	baeS.l6.c4.ctg.1	1866	33.9	0	.	p	.	0	D400E	NONSYN	1198	1200	GAT	1416	1418	GAG	26;24;25	G;A;G	26;24;25	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
cpxA.3000830.NC_002695.4903561_4904935.605	cpxA.3000830.NC_002695.4903561_4904935.605	1	0	27	1446	cpxA	1374	1374	98.91	cpxA.l15.c30.ctg.1	1875	41.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	cpxA;CpxA is a membrane-localized sensor kinase that is activated by envelope stress. It starts a kinase cascade that activates CpxR, which promotes efflux complex expression.
cpxR.3000831.NC_002695.4904931_4905630.142	cpxR.3000831.NC_002695.4904931_4905630.142	1	0	27	902	cpxR	699	699	99.43	cpxR.l15.c30.ctg.1	1226	39.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	cpxR;CpxR is a regulator that promotes acrD expression when phosphorylated by a cascade involving CpxA, a sensor kinase.
cysB.3003840.NC_000913.3.1333854_1334829.3604	cysB.3003840.NC_000913.3.1333854_1334829.3604	1	0	539	1024	cysB	975	975	99.28	cysB.l15.c4.ctg.1	1521	35.8	0	.	p	.	0	A146T	NONSYN	436	438	GCT	732	734	ACT	49;50;49	A;C;T	49;50;49	.	Positive regulator of gene expression in the cysteine regulon. cysB mutants confer resistance to novobiocin, an aminocoumarin antibiotic, in Escherichia coli.;aminocoumarin resistant cysB
dfrA1.3002854.NC_010410.3676915_3677389.140	dfrA1.3002854.NC_010410.3676915_3677389.140	1	0	27	710	dfrA1_1	474	474	100.0	dfrA1_1.l15.c4.ctg.1	1093	34.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	dfrA1 is an integron-encoded dihydrofolate reductase found in Escherichia coli;dfrA1
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	1268	emrA	1173	1173	98.29	emrA.l15.c4.ctg.1	1764	38.4	0	.	p	.	0	I219V	NONSYN	655	657	ATC	1020	1022	GTC	54;55;53	G;T;C	52;51;52	.	EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.;emrA
emrB.3000074.U00096.2812615_2814154.20	emrB.3000074.U00096.2812615_2814154.20	1	0	539	1748	emrB	1539	1539	99.74	emrB.l15.c4.ctg.1	2181	42.6	0	.	p	.	0	E197K	NONSYN	589	591	GAA	977	979	AAA	49;52;53	A;A;A	49;52;53	.	emrB;emrB is a translocase in the emrB -TolC efflux protein in E. coli. It recognizes substrates including carbonyl cyanide m-chlorophenylhydrazone (CCCP), nalidixic acid, and thioloactomycin.
emrD.3000309.GG749185.1.116812_118003.3622	emrD.3000309.GG749185.1.116812_118003.3622	1	0	539	1162	emrD	1191	1191	98.4	emrD.l15.c4.ctg.1	1575	38.3	0	.	p	.	0	G209S	NONSYN	625	627	GGC	942	944	AGC	39;38;38	A;G;C	39;38;38	.	EmrD is a multidrug transporter from the Major Facilitator Superfamily (MFS) primarily found in Escherichia coli. EmrD couples efflux of amphipathic compounds with proton import across the plasma membrane.;emrD
emrE.3000264.NC_007779.567537_567870.260	emrE.3000264.NC_007779.567537_567870.260	1	0	513	58	emrE_1	333	178	90.45	emrE_1.l15.c4.ctg.1	232	4.9	0	.	p	.	0	I100V	NONSYN	298	300	ATT	143	145	GTC	3;3;3	G;T;C	3;3;3	.	emrE;EmrE is a small multidrug transporter that functions as a homodimer and that couples the efflux of small polyaromatic cations from the cell with the import of protons down an electrochemical gradient. EmrE is found in E. coli and P. aeruginosa.
emrE.3000264.NC_007779.567537_567870.260	emrE.3000264.NC_007779.567537_567870.260	1	0	513	58	emrE_1	333	178	90.45	emrE_1.l15.c4.ctg.1	232	4.9	0	.	p	.	0	T108A	NONSYN	322	324	ACA	167	169	GCA	3;3;3	G;C;A	3;3;3	.	emrE;EmrE is a small multidrug transporter that functions as a homodimer and that couples the efflux of small polyaromatic cations from the cell with the import of protons down an electrochemical gradient. EmrE is found in E. coli and P. aeruginosa.
emrE.3000264.NC_007779.567537_567870.260	emrE.3000264.NC_007779.567537_567870.260	1	0	513	58	emrE_1	333	94	96.81	emrE_1.l15.c4.ctg.3	94	14.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrE;EmrE is a small multidrug transporter that functions as a homodimer and that couples the efflux of small polyaromatic cations from the cell with the import of protons down an electrochemical gradient. EmrE is found in E. coli and P. aeruginosa.
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	1028	emrK	1056	1056	98.2	emrK.l15.c4.ctg.1	1614	34.0	0	.	p	.	0	K176R	NONSYN	526	528	AAG	762	764	AGG	25;25;25	A;G;G	25;25;25	.	emrK;emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	1028	emrK	1056	1056	98.2	emrK.l15.c4.ctg.1	1614	34.0	0	.	p	.	0	N306D	NONSYN	916	918	AAC	1152	1154	GAC	26;26;26	G;A;C	26;26;26	.	emrK;emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.
emrR.3000516.NC_000913.3.2810769_2811300.3621	emrR.3000516.NC_000913.3.2810769_2811300.3621	1	0	27	676	emrR	531	531	100.0	emrR.l6.c30.ctg.1	1117	32.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrR;EmrR is a negative regulator for the EmrAB-TolC multidrug efflux pump in E. coli. Mutations lead to EmrAB-TolC overexpression.
emrY.3000254.D78168.1591_3130.65	emrY.3000254.D78168.1591_3130.65	1	0	27	1632	emrY	1539	1539	99.81	emrY.l15.c4.ctg.1	2086	41.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrY;emrY is a multidrug transport that moves substrates across the inner membrane of the Gram-negative E. coli. It is a homolog of emrB.
evgA.3000832.NC_002695.3211891_3212506.208	evgA.3000832.NC_002695.3211891_3212506.208	1	0	539	654	evgA	615	615	99.19	evgA.l15.c30.ctg.1	1175	29.7	0	.	p	.	0	Q62L	NONSYN	184	186	CAG	496	498	CTG	32;33;33	C;T;G	32;32;33	.	EvgA, when phosphorylated, is a positive regulator for efflux protein complexes emrKY and mdtEF. While usually phosphorylated in a EvgS dependent manner, it can be phosphorylated in the absence of EvgS when overexpressed.;evgA
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3032	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4247	38.4	0	.	p	.	0	T38I	NONSYN	112	114	ACA	432	434	ATA	27;25;25	A;T;A	26;25;25	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3032	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4247	38.4	0	.	p	.	0	L42V	NONSYN	124	126	CTA	444	446	GTA	11;12;12	G;T;A	11;12;12	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3032	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4247	38.4	0	.	p	.	0	A93T	NONSYN	277	279	GCG	597	599	ACG	38;39;44	A;C;G	38;39;44	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3032	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4247	38.4	0	.	p	.	0	A114E	NONSYN	340	342	GCA	660	662	GAA	28;29;29	G;A;A	28;29;29	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3032	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4247	38.4	0	.	p	.	0	T127A	NONSYN	379	381	ACT	699	701	GCT	36;36;35	G,C;C;T	33,1;36;33	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3032	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4247	38.4	0	.	p	.	0	N133D	NONSYN	397	399	AAT	717	719	GAT	34;32;32	G;A;T	34;32;32	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3032	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4247	38.4	0	.	p	.	0	P162S	NONSYN	484	486	CCA	804	806	TCA	22;22;21	T;C;A	22;22;21	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3032	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4247	38.4	0	.	p	.	0	H205Q	NONSYN	613	615	CAC	933	935	CAG	31;31;31	C;A;G	31;31;31	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3032	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4247	38.4	0	.	p	.	0	I251V	NONSYN	751	753	ATT	1071	1073	GTT	25;26;24	G;T;T	25;26;24	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3032	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4247	38.4	0	.	p	.	0	N303D	NONSYN	907	909	AAT	1227	1229	GAT	27;27;26	G;A;T	27;27;26	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3032	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4247	38.4	0	.	p	.	0	S359N	NONSYN	1075	1077	AGC	1395	1397	AAT	18;18;18	A;A;T	18;18;18	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3032	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4247	38.4	0	.	p	.	0	I366L	NONSYN	1096	1098	ATA	1416	1418	TTA	7;7;7	T;T;A	7;7;7	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3032	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4247	38.4	0	.	p	.	0	Q433K	NONSYN	1297	1299	CAG	1617	1619	AAA	25;25;25	A;A;A	25;25;25	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3032	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4247	38.4	0	.	p	.	0	N678H	NONSYN	2032	2034	AAT	2352	2354	CAT	42;41;43	C;A;T	42;41;43	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3032	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4247	38.4	0	.	p	.	0	N696H	NONSYN	2086	2088	AAT	2406	2408	CAT	33;34;32	C;A;T	33;34;32	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3032	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4247	38.4	0	.	p	.	0	K702R	NONSYN	2104	2106	AAA	2424	2426	AGA	34;34;37	A;G;A	34;33;36	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3032	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4247	38.4	0	.	p	.	0	K707N	NONSYN	2119	2121	AAG	2439	2441	AAT	38;36;36	A;A;T	38;36;36	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3032	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4247	38.4	0	.	p	.	0	A756S	NONSYN	2266	2268	GCC	2586	2588	TCC	19;19;22	T;C;C	19;18;22	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3032	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4247	38.4	0	.	p	.	0	S811I	NONSYN	2431	2433	AGT	2751	2753	ATT	27;27;29	A;T;T	27;27;29	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3032	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4247	38.4	0	.	p	.	0	E818D	NONSYN	2452	2454	GAA	2772	2774	GAT	31;31;33	G;A;T	30;31;33	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3032	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4247	38.4	0	.	p	.	0	G856V	NONSYN	2566	2568	GGT	2886	2888	GTT	43;43;43	G;T;T	43;43;43	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3032	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4247	38.4	0	.	p	.	0	Q951H	NONSYN	2851	2853	CAA	3171	3173	CAC	35;36;38	C;A;C	34;36;38	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	922	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1353	36.4	1	SNP	p	P64A	0	.	.	190	192	CCA	463	465	CCA	86;84;84	C;C;A	86;83;80	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64A:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	922	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1353	36.4	1	SNP	p	P64S	0	.	.	190	192	CCA	463	465	CCA	86;84;84	C;C;A	86;83;80	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64S:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	922	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1353	36.4	1	SNP	p	P64H	0	.	.	190	192	CCA	463	465	CCA	86;84;84	C;C;A	86;83;80	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64H:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	922	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1353	36.4	1	SNP	p	P64R	0	.	.	190	192	CCA	463	465	CCA	86;84;84	C;C;A	86;83;80	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64R:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	922	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1353	36.4	1	SNP	p	P64L	0	.	.	190	192	CCA	463	465	CCA	86;84;84	C;C;A	86;83;80	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64L:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
gadE.3003834.NC_000913.3.3658365_3658893.3597	gadE.3003834.NC_000913.3.3658365_3658893.3597	1	0	27	712	gadE	528	528	100.0	gadE.l15.c4.ctg.1	1168	32.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadE;gadE is a DNA-binding transcriptional activator that regulates the expression of genes involved in acid resistance. It is required for the expression of gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	513	198	gadW	729	231	96.1	gadW.l15.c4.ctg.1	351	16.5	0	.	p	.	0	S234A	NONSYN	700	702	TCG	202	204	GCG	11;11;11	G;C;G	11;11;11	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	513	198	gadW	729	403	93.3	gadW.l15.c4.ctg.2	403	11.4	0	.	p	.	0	Q21H	NONSYN	61	63	CAA	5	7	CAT	2;2;2	C;A;T	2;2;2	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	513	198	gadW	729	403	93.3	gadW.l15.c4.ctg.2	403	11.4	0	.	p	.	0	L31V	NONSYN	91	93	CTG	35	37	GTG	8;8;8	G;T;G	8;8;8	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	513	198	gadW	729	403	93.3	gadW.l15.c4.ctg.2	403	11.4	0	.	p	.	0	D34E	NONSYN	100	102	GAT	44	46	GAG	9;9;9	G;A;G	9;9;9	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	513	198	gadW	729	403	93.3	gadW.l15.c4.ctg.2	403	11.4	0	.	p	.	0	L46P	NONSYN	136	138	CTG	80	82	CCG	7;7;8	C;C;G	7;7;8	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	513	198	gadW	729	403	93.3	gadW.l15.c4.ctg.2	403	11.4	0	.	p	.	0	E54D	NONSYN	160	162	GAA	104	106	GAT	11;13;14	G;A;T	11;12;14	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	513	198	gadW	729	403	93.3	gadW.l15.c4.ctg.2	403	11.4	0	.	p	.	0	I88M	NONSYN	262	264	ATA	206	208	ATG	6;6;6	A;T;G	6;6;6	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	513	198	gadW	729	403	93.3	gadW.l15.c4.ctg.2	403	11.4	0	.	p	.	0	Q89P	NONSYN	265	267	CAG	209	211	CCG	7;6;6	C;C;G	7;6;6	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	513	198	gadW	729	403	93.3	gadW.l15.c4.ctg.2	403	11.4	0	.	p	.	0	D100E	NONSYN	298	300	GAC	242	244	GAA	4;4;4	G;A;A	4;4;4	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	513	198	gadW	729	403	93.3	gadW.l15.c4.ctg.2	403	11.4	0	.	p	.	0	P101S	NONSYN	301	303	CCC	245	247	TCC	4;4;5	T;C;C	4;4;5	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	513	198	gadW	729	403	93.3	gadW.l15.c4.ctg.2	403	11.4	0	.	p	.	0	R102G	NONSYN	304	306	CGG	248	250	GGG	5;5;5	G;G;G	5;5;5	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	513	198	gadW	729	403	93.3	gadW.l15.c4.ctg.2	403	11.4	0	.	p	.	0	K110N	NONSYN	328	330	AAA	272	274	AAT	7;8;8	A;A;T	7;8;7	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	672	gadX	825	825	97.94	gadX.l6.c30.ctg.1	1315	27.2	0	.	p	.	0	F53L	NONSYN	157	159	TTC	421	423	TTA	21;21;20	T;T;A	21;21;20	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	672	gadX	825	825	97.94	gadX.l6.c30.ctg.1	1315	27.2	0	.	p	.	0	V79I	NONSYN	235	237	GTT	499	501	ATT	38;36;37	A;T;T	37;36;37	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	672	gadX	825	825	97.94	gadX.l6.c30.ctg.1	1315	27.2	0	.	p	.	0	R246G	NONSYN	736	738	AGA	1000	1002	GGA	37;36;35	G;G;A	37;36;35	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	672	gadX	825	825	97.94	gadX.l6.c30.ctg.1	1315	27.2	0	.	p	.	0	S248P	NONSYN	742	744	TCG	1006	1008	CCG	31;31;32	C;C;G	31;31;32	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	3190	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3243	52.5	0	.	p	.	0	D678E	NONSYN	2032	2034	GAC	2321	2323	GAA	50;51;50	G;A;A	50;51;50	.	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	3190	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3243	52.5	1	SNP	p	S83I	0	.	.	247	249	TCG	536	538	TCG	65;66;65	T;C;G	64;66;64	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83I:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	3190	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3243	52.5	1	SNP	p	S83L	0	.	.	247	249	TCG	536	538	TCG	65;66;65	T;C;G	64;66;64	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83L:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	3190	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3243	52.5	1	SNP	p	S83W	0	.	.	247	249	TCG	536	538	TCG	65;66;65	T;C;G	64;66;64	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83W:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	3190	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3243	52.5	1	SNP	p	D87N	0	.	.	259	261	GAC	548	550	GAC	70;69;67	G;A;C	69;66;66	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87N:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	3190	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3243	52.5	1	SNP	p	D87Y	0	.	.	259	261	GAC	548	550	GAC	70;69;67	G;A;C	69;66;66	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87Y:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	3190	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3243	52.5	1	SNP	p	D87V	0	.	.	259	261	GAC	548	550	GAC	70;69;67	G;A;C	69;66;66	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87V:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	3190	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3243	52.5	1	SNP	p	D87G	0	.	.	259	261	GAC	548	550	GAC	70;69;67	G;A;C	69;66;66	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87G:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	3190	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3243	52.5	1	SNP	p	D87H	0	.	.	259	261	GAC	548	550	GAC	70;69;67	G;A;C	69;66;66	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87H:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2490	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	3033	43.8	1	SNP	p	R136S	0	.	.	406	408	CGC	730	732	CGC	48;46;48	C;G;C	48;46;48	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136S:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2490	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	3033	43.8	1	SNP	p	R136C	0	.	.	406	408	CGC	730	732	CGC	48;46;48	C;G;C	48;46;48	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136C:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2490	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	3033	43.8	1	SNP	p	R136G	0	.	.	406	408	CGC	730	732	CGC	48;46;48	C;G;C	48;46;48	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136G:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2490	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	3033	43.8	1	SNP	p	R136L	0	.	.	406	408	CGC	730	732	CGC	48;46;48	C;G;C	48;46;48	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136L:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2490	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	3033	43.8	1	SNP	p	R136E	0	.	.	406	408	CGC	730	732	CGC	48;46;48	C;G;C	48;46;48	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136E:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2490	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	3033	43.8	1	SNP	p	R136H	0	.	.	406	408	CGC	730	732	CGC	48;46;48	C;G;C	48;46;48	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136H:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2490	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	3033	43.8	1	SNP	p	R136I	0	.	.	406	408	CGC	730	732	CGC	48;46;48	C;G;C	48;46;48	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136I:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	610	kdpE	678	678	98.23	kdpE.l15.c17.ctg.1	1251	25.9	0	.	p	.	0	A72P	NONSYN	214	216	GCG	566	568	CCG	34;35;36	C;C;G	34;35;36	.	kdpE;kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	610	kdpE	678	678	98.23	kdpE.l15.c17.ctg.1	1251	25.9	0	.	p	.	0	T123A	NONSYN	367	369	ACC	719	721	GCC	34;33;32	G;C;C	34;33;30	.	kdpE;kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.
leuO.3003843.NC_000913.3.84367_85312.3607	leuO.3003843.NC_000913.3.84367_85312.3607	1	0	539	1160	leuO	945	945	99.26	leuO.l15.c30.ctg.1	1495	41.4	0	.	p	.	0	P9S	NONSYN	25	27	CCA	254	256	TCA	29;30;30	T;C;A	29;30;28	.	leuO;leuO, a LysR family transcription factor, exists in a wide variety of bacteria of the family Enterobacteriaceae and is involved in the regulation of as yet unidentified genes affecting the stress response and pathogenesis expression.
marA.3000263.NC_007779.1621287_1621671.579	marA.3000263.NC_007779.1621287_1621671.579	1	0	27	464	marA	384	384	99.74	marA.l6.c4.ctg.1	1034	24.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	In the presence of antibiotic stress, E. coli overexpresses the global activator protein MarA, which besides inducing MDR efflux pump AcrAB, also down- regulates synthesis of the porin OmpF.;marA
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	316	marR	435	435	97.7	marR.l15.c17.ctg.1	900	18.5	1	SNP	p	G103S	1	G103S	NONSYN	307	309	GGC	558	560	AGC	26;23;20	A;G;C	26;23;20	marR.3003378.U00096.1619119_1619554.2097:1:1:G103S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	316	marR	435	435	97.7	marR.l15.c17.ctg.1	900	18.5	1	SNP	p	Y137H	1	Y137H	NONSYN	409	411	TAT	660	662	CAT	16;15;15	C;A;T	15;15;15	marR.3003378.U00096.1619119_1619554.2097:1:1:Y137H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	316	marR	435	435	97.7	marR.l15.c17.ctg.1	900	18.5	1	SNP	p	V45E	0	.	.	133	135	GTG	384	386	GTG	38;38;38	G;T;G	38;38;38	marR.3003378.U00096.1619119_1619554.2097:1:1:V45E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	316	marR	435	435	97.7	marR.l15.c17.ctg.1	900	18.5	1	SNP	p	I49S	0	.	.	145	147	ATC	396	398	ATC	33;33;33	A;T;C	33;33;33	marR.3003378.U00096.1619119_1619554.2097:1:1:I49S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	316	marR	435	435	97.7	marR.l15.c17.ctg.1	900	18.5	1	SNP	p	A70T	0	.	.	208	210	GCA	459	461	GCA	38;40;40	G;C;A	38;40;40	marR.3003378.U00096.1619119_1619554.2097:1:1:A70T:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	316	marR	435	435	97.7	marR.l15.c17.ctg.1	900	18.5	1	SNP	p	R73S	0	.	.	217	219	CGT	468	470	CGT	35;35;34	C;G;T	35;35;34	marR.3003378.U00096.1619119_1619554.2097:1:1:R73S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	316	marR	435	435	97.7	marR.l15.c17.ctg.1	900	18.5	1	SNP	p	R73C	0	.	.	217	219	CGT	468	470	CGT	35;35;34	C;G;T	35;35;34	marR.3003378.U00096.1619119_1619554.2097:1:1:R73C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	316	marR	435	435	97.7	marR.l15.c17.ctg.1	900	18.5	1	SNP	p	R77C	0	.	.	229	231	CGC	480	482	CGC	29;29;28	C;G;C	29;29;28	marR.3003378.U00096.1619119_1619554.2097:1:1:R77C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	316	marR	435	435	97.7	marR.l15.c17.ctg.1	900	18.5	1	SNP	p	R77L	0	.	.	229	231	CGC	480	482	CGC	29;29;28	C;G;C	29;29;28	marR.3003378.U00096.1619119_1619554.2097:1:1:R77L:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	316	marR	435	435	97.7	marR.l15.c17.ctg.1	900	18.5	1	SNP	p	L78M	0	.	.	232	234	CTG	483	485	CTG	29;27;24	C;T;G	29;27;24	marR.3003378.U00096.1619119_1619554.2097:1:1:L78M:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	316	marR	435	435	97.7	marR.l15.c17.ctg.1	900	18.5	1	SNP	p	R94S	0	.	.	280	282	CGC	531	533	CGC	21;22;22	C;G;C	21;22;22	marR.3003378.U00096.1619119_1619554.2097:1:1:R94S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	316	marR	435	435	97.7	marR.l15.c17.ctg.1	900	18.5	1	SNP	p	R94H	0	.	.	280	282	CGC	531	533	CGC	21;22;22	C;G;C	21;22;22	marR.3003378.U00096.1619119_1619554.2097:1:1:R94H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	316	marR	435	435	97.7	marR.l15.c17.ctg.1	900	18.5	1	SNP	p	V96E	0	.	.	286	288	GTA	537	539	GTA	22;22;23	G;T;A	22;22;23	marR.3003378.U00096.1619119_1619554.2097:1:1:V96E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	942	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1402	34.3	0	.	p	.	0	S7F	NONSYN	19	21	TCC	19	21	TTC	8;8;8	T;T;C	8;8;8	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	942	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1402	34.3	0	.	p	.	0	R36I	NONSYN	106	108	AGG	106	108	ATC	24;25;24	A;T;C	24;25;24	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	942	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1402	34.3	0	.	p	.	0	E42A	NONSYN	124	126	GAA	124	126	GCC	11;11;11	G;C;C	11;11;11	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	942	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1402	34.3	0	.	p	.	0	N43V	NONSYN	127	129	AAT	127	129	GTG	12;12;11	G;T;G	12;12;11	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	942	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1402	34.3	0	.	p	.	0	E52D	NONSYN	154	156	GAG	154	156	GAT	22;23;23	G;A;T	21;22;22	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	942	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1402	34.3	0	.	p	.	0	N59T	NONSYN	175	177	AAC	175	177	ACC	19;19;20	A;C;C	19;19;20	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	942	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1402	34.3	0	.	p	.	0	I68L	NONSYN	202	204	ATA	202	204	TTA	23;20;19	T;T;A	23;20;19	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	942	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1402	34.3	0	.	p	.	0	H115Q	NONSYN	343	345	CAC	343	345	CAG	52;45;45	C;A;G	52;45;44	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	942	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1402	34.3	0	.	p	.	0	D128A	NONSYN	382	384	GAC	382	384	GCC	36;36;36	G;C;C	36;36;35	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	942	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1402	34.3	0	.	p	.	0	S163A	NONSYN	487	489	TCG	487	489	GCG	42;42;40	G;C;G	41;41;39	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	942	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1402	34.3	0	.	p	.	0	L231V	NONSYN	691	693	CTT	691	693	GTT	26;27;28	G;T;T	17;25;24	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	942	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1402	34.3	0	.	p	.	0	R285fs	FSHIFT	853	853	C	853	853	C	26	C	26	.	mdfA;Multidrug translocase MdfA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	936	mdtA	1248	1248	97.36	mdtA.l15.c30.ctg.1	1681	29.6	0	.	p	.	0	V12trunc	TRUNC	34	34	G	242	242	G	31	G	31	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	936	mdtA	1248	1248	97.36	mdtA.l15.c30.ctg.1	1681	29.6	0	.	p	.	0	R33Q	NONSYN	97	99	CGG	299	301	CAG	14;15;15	C;A;G	12;15;15	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	936	mdtA	1248	1248	97.36	mdtA.l15.c30.ctg.1	1681	29.6	0	.	p	.	0	T83I	NONSYN	247	249	ACC	449	451	ATC	17;16;14	A;T;C	17;14;14	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	936	mdtA	1248	1248	97.36	mdtA.l15.c30.ctg.1	1681	29.6	0	.	p	.	0	I99M	NONSYN	295	297	ATA	497	499	ATG	20;20;22	A;T;G	20;20;22	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	936	mdtA	1248	1248	97.36	mdtA.l15.c30.ctg.1	1681	29.6	0	.	p	.	0	A130T	NONSYN	388	390	GCC	590	592	ACC	17;16;14	A;C;C	16;15;13	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	936	mdtA	1248	1248	97.36	mdtA.l15.c30.ctg.1	1681	29.6	0	.	p	.	0	P257T	NONSYN	769	771	CCG	971	973	ACG	33;32;30	A;C;G	32;32;30	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	3024	mdtB	3123	3123	98.98	mdtB.l6.c30.ctg.1	3629	44.6	0	.	p	.	0	A583T	NONSYN	1747	1749	GCC	2032	2034	ACC	71;71;68	A;C;C	69;71;67	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	3024	mdtB	3123	3123	98.98	mdtB.l6.c30.ctg.1	3629	44.6	0	.	p	.	0	K714Q	NONSYN	2140	2142	AAA	2425	2427	CAA	33;34;35	C;A;A	27;34;31	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	3024	mdtB	3123	3123	98.98	mdtB.l6.c30.ctg.1	3629	44.6	0	.	p	.	0	N770I	NONSYN	2308	2310	AAT	2593	2595	ATT	27;28;29	A;T;T	27;28;29	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	3024	mdtB	3123	3123	98.98	mdtB.l6.c30.ctg.1	3629	44.6	0	.	p	.	0	I798V	NONSYN	2392	2394	ATT	2677	2679	GTT	36;35;36	G;T;T	36;35;36	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	3024	mdtB	3123	3123	98.98	mdtB.l6.c30.ctg.1	3629	44.6	0	.	p	.	0	A834E	NONSYN	2500	2502	GCG	2785	2787	GAG	32;32;35	G;A;G	32;32;35	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	3024	mdtB	3123	3123	98.98	mdtB.l6.c30.ctg.1	3629	44.6	0	.	p	.	0	L910M	NONSYN	2728	2730	CTG	3013	3015	ATG	35;37;38	A;T;G	35;37;37	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	3024	mdtB	3123	3123	98.98	mdtB.l6.c30.ctg.1	3629	44.6	0	.	p	.	0	E955D	NONSYN	2863	2865	GAG	3148	3150	GAT	52;52;52	G;A,G;T	52;50,1;52	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2798	mdtC	3078	3078	98.64	mdtC.l15.c4.ctg.1	3395	43.4	0	.	p	.	0	I46M	NONSYN	136	138	ATC	402	404	ATG	26;26;26	A;T,C;G	26;25,1;26	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2798	mdtC	3078	3078	98.64	mdtC.l15.c4.ctg.1	3395	43.4	0	.	p	.	0	V208I	NONSYN	622	624	GTC	888	890	ATC	46;46;46	A;T;C	46;46;46	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2798	mdtC	3078	3078	98.64	mdtC.l15.c4.ctg.1	3395	43.4	0	.	p	.	0	Q980H	NONSYN	2938	2940	CAA	3204	3206	CAC	8;8;8	C;A;C	8;8;8	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2798	mdtC	3078	3078	98.64	mdtC.l15.c4.ctg.1	3395	43.4	0	.	p	.	0	P981L	NONSYN	2941	2943	CCC	3207	3209	CTC	8;8;8	C;T;C	8;8;8	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1486	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1901	41.8	0	.	p	.	0	D3E	NONSYN	7	9	GAT	228	230	GAA	22;22;23	G;A;A	22;22;23	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1486	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1901	41.8	0	.	p	.	0	T226A	NONSYN	676	678	ACG	897	899	GCG	48;46;48	G;C;G	48;46;48	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1486	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1901	41.8	0	.	p	.	0	V340I	NONSYN	1018	1020	GTC	1239	1241	ATC	60;61;60	A;T;C	59;61;59	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1486	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1901	41.8	0	.	p	.	0	L441F	NONSYN	1321	1323	TTG	1542	1544	TTT	61;61;63	T;T;T	61;61;63	.	mdtD;Efflux pump mdtD
mdtE.3000795.AP009048.3980025_3981183.753	mdtE.3000795.AP009048.3980025_3981183.753	1	0	27	1346	mdtE	1158	1158	99.31	mdtE.l15.c4.ctg.1	1775	40.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	MdtE is the membrane fusion protein of the MdtEF multidrug efflux complex. It shares 70% sequence similarity with AcrA.;mdtE
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	3514	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3629	51.8	0	.	p	.	0	A295T	NONSYN	883	885	GCC	1134	1136	ACC	43;41;41	A;C,A;C,A	43;37,2;40,1	.	mdtF;MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	3514	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3629	51.8	0	.	p	.	0	N709D	NONSYN	2125	2127	AAT	2376	2378	GAC	64;64;61	G;A;C	63;64;60	.	mdtF;MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	1414	mdtG	1227	182	99.45	mdtG.l15.c30.ctg.1	654	18.3	0	.	p	.	0	E5G	NONSYN	13	15	GAA	213	215	GGA	9;9;10	G;G;A	9;9;10	.	Efflux protien mdtG.;mdtG
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	1414	mdtG	1227	1047	99.33	mdtG.l15.c30.ctg.2	1653	38.2	0	.	p	.	0	V200I	NONSYN	598	600	GTC	685	687	ATC	51;53;53	A;T;C	51;53;53	.	Efflux protien mdtG.;mdtG
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	1120	mdtH	1209	1209	98.18	mdtH.l6.c30.ctg.1	1665	35.7	0	.	p	.	0	G134C	NONSYN	400	402	GGT	618	620	TGT	45;46;47	T;G;T	45;45;47	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	1120	mdtH	1209	1209	98.18	mdtH.l6.c30.ctg.1	1665	35.7	0	.	p	.	0	S324L	NONSYN	970	972	TCG	1188	1190	TTG	37;38;38	T;T;G	37;38;38	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	1120	mdtH	1209	1209	98.18	mdtH.l6.c30.ctg.1	1665	35.7	0	.	p	.	0	A394T	NONSYN	1180	1182	GCG	1398	1400	ACG	13;14;14	A;C;G	12;14;14	.	Multidrug resistance protein MdtH;mdtH
mdtL.3001215.U00096.3891614_3892790.621	mdtL.3001215.U00096.3891614_3892790.621	1	0	539	1502	mdtL	1176	1176	98.38	mdtL.l15.c4.ctg.1	1787	45.1	0	.	p	.	0	A185S	NONSYN	553	555	GCC	834	836	TCC	48;46;47	T;C;C	47;46;46	.	mdtL;Multidrug resistance protein MdtL
mdtN.3003548.AP009048.4306556_4307588.3298	mdtN.3003548.AP009048.4306556_4307588.3298	1	0	539	920	mdtN	1032	1032	98.06	mdtN.l15.c30.ctg.1	1560	31.5	0	.	p	.	0	V119I	NONSYN	355	357	GTT	619	621	ATT	25;24;25	A;T;T	24;24;24	.	mdtN;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride.
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2028	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2648	40.9	0	.	p	.	0	V11M	NONSYN	31	33	GTG	278	280	ATG	18;20;21	A;T;G	18;20;21	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2028	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2648	40.9	0	.	p	.	0	T33I	NONSYN	97	99	ACC	344	346	ATC	22;22;23	A;T;C	20;22;23	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2028	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2648	40.9	0	.	p	.	0	C116R	NONSYN	346	348	TGC	593	595	CGC	58;58;58	C;G;C	58;58;57	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2028	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2648	40.9	0	.	p	.	0	N238S	NONSYN	712	714	AAC	959	961	AGC	38;39;41	A;G;C	38;39;41	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2028	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2648	40.9	0	.	p	.	0	M305V	NONSYN	913	915	ATG	1160	1162	GTG	41;42;40	G;T;G	41;40;40	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2028	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2648	40.9	0	.	p	.	0	D326N	NONSYN	976	978	GAC	1223	1225	AAC	22;21;21	A;A,C;C	20;19,1;20	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2028	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2648	40.9	0	.	p	.	0	A341V	NONSYN	1021	1023	GCC	1268	1270	GTC	51;51;54	G;T;C	51;49;54	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2028	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2648	40.9	0	.	p	.	0	M351I	NONSYN	1051	1053	ATG	1298	1300	ATA	62;60;60	A;T;A	62;60;60	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2028	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2648	40.9	0	.	p	.	0	A387S	NONSYN	1159	1161	GCT	1406	1408	TCT	34;32;32	T;C;T	34;32;32	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2028	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2648	40.9	0	.	p	.	0	T516A	NONSYN	1546	1548	ACG	1793	1795	GCG	53;54;53	G;C;G	52;49;53	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2028	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2648	40.9	0	.	p	.	0	L587I	NONSYN	1759	1761	CTT	2006	2008	ATC	49;49;49	A;T;C	48;48;49	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1244	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1991	33.4	0	.	p	.	0	S129A	NONSYN	385	387	TCA	617	619	GCG	28;28;26	G;C;G	28;28;26	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1244	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1991	33.4	0	.	p	.	0	A187T	NONSYN	559	561	GCC	791	793	ACC	32;34;33	A;C;C	32;34;33	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1244	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1991	33.4	0	.	p	.	0	H211R	NONSYN	631	633	CAC	863	865	CGC	42;44;44	C;G;C	41;44;44	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1244	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1991	33.4	0	.	p	.	0	V250A	NONSYN	748	750	GTT	980	982	GCT	44;44;44	G;C;T	43;44;44	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1244	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1991	33.4	0	.	p	.	0	R278K	NONSYN	832	834	AGA	1064	1066	AAA	26;25;27	A;A;A	26;25;27	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1244	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1991	33.4	0	.	p	.	0	Q284R	NONSYN	850	852	CAA	1082	1084	CGA	33;34;33	C;G;A	33;34;33	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1244	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1991	33.4	0	.	p	.	0	S339A	NONSYN	1015	1017	TCC	1247	1249	GCC	33;34;34	G;C;C	33;34;34	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1244	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1991	33.4	0	.	p	.	0	H343D	NONSYN	1027	1029	CAT	1259	1261	GAT	38;37;37	G;A;T	38;37;37	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1244	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1991	33.4	0	.	p	.	0	G482A	NONSYN	1444	1446	GGT	1676	1678	GCT	14;14;14	G;C;T	14;14;13	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	3582	mfd	3447	3447	99.16	mfd.l6.c4.ctg.1	4053	47.3	0	.	p	.	0	T437K	NONSYN	1309	1311	ACG	1641	1643	AAG	40;41;40	A;A;G	40;40;40	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	3582	mfd	3447	3447	99.16	mfd.l6.c4.ctg.1	4053	47.3	0	.	p	.	0	M796L	NONSYN	2386	2388	ATG	2718	2720	CTG	55;55;54	C;T;G	53;54;54	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mgrB.3003820.NC_000913.3.1908622_1908766.3586	mgrB.3003820.NC_000913.3.1908622_1908766.3586	1	0	27	226	mgrB	144	144	100.0	mgrB.l15.c30.ctg.2	158	38.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mgrB;mgrB is a small transmembrane protein produced in the PhoPQ signalling system. It acts as a negative regulator in this system. Inactivation or down-regulation of mgrB confers colistin resistance by absence as shown in Klebsiella pneumoniae
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	2208	msbA	1749	1749	98.68	msbA.l15.c30.ctg.1	2320	51.0	0	.	p	.	0	S278N	NONSYN	832	834	AGC	1059	1061	AAC	48;52;54	A;A;C	48;52;53	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	2208	msbA	1749	1749	98.68	msbA.l15.c30.ctg.1	2320	51.0	0	.	p	.	0	M460I	NONSYN	1378	1380	ATG	1605	1607	ATA	61;62;63	A;T;A	61;62;63	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	1452	murA_12	1260	1260	98.49	murA_12.l15.c4.ctg.1	1792	43.2	1	SNP	p	D369N	0	.	.	1105	1107	GAT	1351	1353	GAT	58;57;56	G;A;T	58;55;56	murA.3003775.CP009072.1414817_1416077.3548:1:1:D369N:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	1452	murA_12	1260	1260	98.49	murA_12.l15.c4.ctg.1	1792	43.2	1	SNP	p	L370I	0	.	.	1108	1110	CTG	1354	1356	CTG	56;56;54	C;T;G	56;54;54	murA.3003775.CP009072.1414817_1416077.3548:1:1:L370I:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	528	466	nfsA	723	405	99.01	nfsA.l6.c30.ctg.1	1053	23.6	0	.	p	.	0	R27C	NONSYN	79	81	CGT	411	413	TGT	27;26;27	T;G;T	27;26;27	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	528	466	nfsA	723	405	99.01	nfsA.l6.c30.ctg.1	1053	23.6	0	.	p	.	0	I117T	NONSYN	349	351	ATC	681	683	ACC	37;36;36	A;C;C	37;35;35	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	528	466	nfsA	723	405	99.01	nfsA.l6.c30.ctg.1	1053	23.6	1	SNP	p	R15C	0	.	.	43	45	CGC	375	377	CGC	50;47;46	C;G;C	50;47;46	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R15C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	528	466	nfsA	723	405	99.01	nfsA.l6.c30.ctg.1	1053	23.6	1	SNP	p	S33R	0	.	.	97	99	AGC	429	431	AGC	31;31;31	A;G;C,A	31;30;30,1	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:S33R:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	528	466	nfsA	723	405	99.01	nfsA.l6.c30.ctg.1	1053	23.6	1	SNP	p	G131D	0	.	.	391	393	GGC	723	725	GGC	23;22;26	G;G;C	23;22;25	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:G131D:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1538	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1480	53.7	0	.	p	.	0	D312E	NONSYN	934	936	GAT	974	976	GAG	57;53;54	G,C;A;G	56,1;53;54	.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1538	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1480	53.7	1	SNP	p	G141E	0	.	.	421	423	GGT	461	463	GGT	64;65;64	G;G;T	64;65;64	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141E:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1538	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1480	53.7	1	SNP	p	G141D	0	.	.	421	423	GGT	461	463	GGT	64;65;64	G;G;T	64;65;64	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1538	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1480	53.7	1	SNP	p	R154D	0	.	.	460	462	CGT	500	502	CGT	81;82;82	C;G;T	80;81;82	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1538	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1480	53.7	1	SNP	p	R154A	0	.	.	460	462	CGT	500	502	CGT	81;82;82	C;G;T	80;81;82	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154A:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2688	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2844	50.5	0	.	p	.	0	A533V	NONSYN	1597	1599	GCG	1880	1882	GTG	59;60;60	G;T;G	59;60;59	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2688	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2844	50.5	0	.	p	.	0	P542S	NONSYN	1624	1626	CCG	1907	1909	TCG	64;62;60	T;C;G	59;58;58	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2688	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2844	50.5	0	.	p	.	0	S747N	NONSYN	2239	2241	AGC	2522	2524	AAC	45;44;44	A;A;C	45;44;44	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2688	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2844	50.5	1	SNP	p	A85T	0	.	.	253	255	GCG	536	538	GCG	48;47;47	G;C;G	42;45;43	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:A85T:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2688	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2844	50.5	1	SNP	p	D111H	0	.	.	331	333	GAT	614	616	GAT	37;39;40	G;A;T	37;39;40	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:D111H:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2688	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2844	50.5	1	SNP	p	S129P	0	.	.	385	387	TCC	668	670	TCC	64;61;60	T;C;C	63;61;59	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:S129P:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	515	1764	parE_1	1893	1751	97.43	parE_1.l15.c17.ctg.1	1920	43.7	0	.	p	.	0	D473N	NONSYN	1417	1419	GAC	1275	1277	AAC	55;56;57	A,C;A;C	53,1;56;56	.	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	515	1764	parE_1	1893	1751	97.43	parE_1.l15.c17.ctg.1	1920	43.7	1	SNP	p	D476N	0	.	.	1426	1428	GAT	1284	1286	GAT	61;60;59	G;A;T	60;60;58	parE.3003316.NC_007779.3172159_3174052.2073:1:1:D476N:.:Point mutation in Escherichia coli parE resulting in fluoroquinolones resistance	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	515	1764	parE_1	1893	155	98.06	parE_1.l15.c17.ctg.2	433	21.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli parE conferring resistance to fluoroquinolones
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	1630	patA	1380	1380	99.78	patA.l15.c4.ctg.1	1984	43.9	0	.	p	.	0	P202Q	NONSYN	604	606	CCG	893	895	CAG	43;44;43	C;A;G	43;44;43	.	PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.;patA
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	1630	patA	1380	1380	99.78	patA.l15.c4.ctg.1	1984	43.9	0	.	p	.	0	E360D	NONSYN	1078	1080	GAG	1367	1369	GAT	52;53;52	G;A;T	51;52;52	.	PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.;patA
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	5136	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4585	59.8	1	SNP	p	V146F	0	.	.	436	438	GTT	742	744	GTT	59;60;62	G;T;T	58;60;62	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:V146F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	5136	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4585	59.8	1	SNP	p	Q513L	0	.	.	1537	1539	CAG	1843	1845	CAG	79;79;76	C;A;G	79;79;76	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	5136	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4585	59.8	1	SNP	p	Q513P	0	.	.	1537	1539	CAG	1843	1845	CAG	79;79;76	C;A;G	79;79;76	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	5136	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4585	59.8	1	SNP	p	H526Y	0	.	.	1576	1578	CAC	1882	1884	CAC	57;59;61	C;A;C	57;59;61	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:H526Y:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	5136	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4585	59.8	1	SNP	p	R529C	0	.	.	1585	1587	CGT	1891	1893	CGT	56;55;55	C;G;T	55;55;55	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529C:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	5136	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4585	59.8	1	SNP	p	R529S	0	.	.	1585	1587	CGT	1891	1893	CGT	56;55;55	C;G;T	55;55;55	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529S:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	5136	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4585	59.8	1	SNP	p	S531F	0	.	.	1591	1593	TCC	1897	1899	TCC	50;50;50	T;C;C	50;50;49	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:S531F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	5136	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4585	59.8	1	SNP	p	L533P	0	.	.	1597	1599	CTC	1903	1905	CTC	44;44;42	C;T;C	44;44;42	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:L533P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	5136	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4585	59.8	1	SNP	p	T563P	0	.	.	1687	1689	ACC	1993	1995	ACC	80;80;79	A;C;C	80;80;79	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:T563P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	5136	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4585	59.8	1	SNP	p	P564L	0	.	.	1690	1692	CCT	1996	1998	CCT	78;78;78	C;C;T	78;78;77	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:P564L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	5136	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4585	59.8	1	SNP	p	R687H	0	.	.	2059	2061	CGT	2365	2367	CGT	99;100;100	C;G;T	98;100;99	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R687H:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	13068	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1601	394.2	0	.	n	.	0	A226G	SNP	226	226	A	272	272	G	443	G	441	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	13068	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1601	394.2	1	SNP	n	A794G	0	.	.	794	794	A	840	840	A	377	A	367	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	13068	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1601	394.2	1	SNP	n	A794T	0	.	.	794	794	A	840	840	A	377	A	367	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	13068	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1601	394.2	1	SNP	n	G926A	0	.	.	926	926	G	972	972	G	401	G	399	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926A:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	13068	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1601	394.2	1	SNP	n	G926T	0	.	.	926	926	G	972	972	G	401	G	399	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	13068	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1601	394.2	1	SNP	n	G926C	0	.	.	926	926	G	972	972	G	401	G	399	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	13068	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1601	394.2	1	SNP	n	A1519C	0	.	.	1519	1519	A	1565	1565	A	311	A	306	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	13068	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1601	394.2	1	SNP	n	A1519T	0	.	.	1519	1519	A	1565	1565	A	311	A	306	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	13068	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1601	394.2	1	SNP	n	A1519G	0	.	.	1519	1519	A	1565	1565	A	311	A	306	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	13068	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1601	394.2	0	HET	.	.	.	C183T	.	183	183	C	229	229	C	340	C,T	228,111	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	13068	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1601	394.2	0	HET	.	.	.	C719T	.	719	719	C	765	765	C	360	C,T	215,142	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	13068	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1601	394.2	0	HET	.	.	.	A250T	.	250	250	A	296	296	A	379	A,T	285,91	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	13068	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1601	394.2	0	HET	.	.	.	T90C	.	90	90	T	136	136	T	325	T,C	250,70	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	13068	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1601	394.2	0	HET	.	.	.	G474A	.	474	474	G	520	520	G	426	G,A	326,95	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	13068	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1601	394.2	0	HET	.	.	.	A253T	.	253	253	A	299	299	A	376	A,T	283,92	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	13068	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1601	394.2	0	HET	.	.	.	C1038T	.	1038	1038	C	1084	1084	C	371	C,T	232,137	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	13068	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1601	394.2	0	HET	.	.	.	C194T	.	194	194	C	240	240	C	387	C,T	314,71	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	13068	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1601	394.2	0	HET	.	.	.	G1002A,T,C	.	1002	1002	G	1048	1048	G	358	G,A,T,C	208,144,1,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	13068	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1601	394.2	0	HET	.	.	.	G1006C	.	1006	1006	G	1052	1052	G	358	G,C	214,138	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	13068	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1601	394.2	0	HET	.	.	.	A79G,C	.	79	79	A	125	125	A	338	A,G,C	261,68,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	13068	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1601	394.2	0	HET	.	.	.	T273A	.	273	273	T	319	319	T	369	T,A	268,90	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	13068	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1601	394.2	0	HET	.	.	.	T1010C,G	.	1010	1010	T	1056	1056	T	361	T,C,G	218,132,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
sat_1.3002895.AB211124.0_525.584	sat_1.3002895.AB211124.0_525.584	1	0	27	776	sat_1	525	525	100.0	sat_1.l15.c4.ctg.1	1089	38.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	sat-1;sat-1 is a plasmid-mediated streptothricin acetyltransferase in Escherichia coli
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	666	soxR	465	465	100.0	soxR.l15.c4.ctg.1	977	36.4	1	SNP	p	R20H	0	.	.	58	60	CGC	306	308	CGC	56;57;57	C;G;C	56;57;57	soxR.3003381.U00096.4277468_4277933.2074:1:1:R20H:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	666	soxR	465	465	100.0	soxR.l15.c4.ctg.1	977	36.4	1	SNP	p	G121D	0	.	.	361	363	GGT	609	611	GGT	55;54;54	G;G;T	55;54;54	soxR.3003381.U00096.4277468_4277933.2074:1:1:G121D:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxS.3003511.NC_000913.4277059_4277383.3528	soxS.3003511.NC_000913.4277059_4277383.3528	1	1	27	460	soxS_1	324	324	99.69	soxS_1.l15.c30.ctg.1	936	26.4	1	SNP	p	A12S	0	.	.	34	36	GCA	379	381	GCA	58;59;60	G;C;A	57;59;60	soxS.3003511.NC_000913.4277059_4277383.3528:1:1:A12S:.:SoxS is a global regulator that up-regulates the expression of AcrAB efflux genes. It also reduces OmpF expression to decrease cell membrane permeability.	Escherichia coli soxS mutant
strA.manually_added_NC_009345_WP_001082319.1_6656_7459	strA.manually_added_NC_009345_WP_001082319.1_6656_7459	1	0	16	28	APH_3____Ib+	804	153	99.35	APH_3____Ib+.l15.c30.ctg.1	159	2.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
sul2.manually_added_NC_009345_WP_001043267.1_5780_6595	sul2.manually_added_NC_009345_WP_001043267.1_5780_6595	1	0	16	26	sul2	816	277	100.0	sul2.l6.c30.ctg.1	277	1.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tetA.manually_added_NC_009345_WP_000804063.1_1230_2429	tetA.manually_added_NC_009345_WP_000804063.1_1230_2429	1	0	528	46	tetA	1200	136	99.26	tetA.l15.c30.ctg.1	136	2.0	0	.	p	.	0	Q263P	NONSYN	787	789	CAG	3	5	CCG	1;1;1	C;C;G	1;0;1	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tetR.manually_added_NC_009345_WP_000164043.1_474_1124	tetR.manually_added_NC_009345_WP_000164043.1_474_1124	1	0	512	28	tetR	651	129	100.0	tetR.l6.c30.ctg.1	177	2.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tetR.manually_added_NC_009345_WP_000164043.1_474_1124	tetR.manually_added_NC_009345_WP_000164043.1_474_1124	1	0	512	28	tetR	651	180	99.44	tetR.l6.c30.ctg.2	190	1.7	0	.	p	.	0	L16R	NONSYN	46	48	CTG	56	58	CGG	1;1;1	C;G;G	1;1;1	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tolC.3000237.FJ768952.0_1488.563	tolC.3000237.FJ768952.0_1488.563	1	0	27	1782	tolC	1488	1488	98.72	tolC.l6.c30.ctg.1	2181	43.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	TolC is a protein subunit of many multidrug efflux complexes in Gram negative bacteria. It is an outer membrane efflux protein and is constitutively open. Regulation of efflux activity is often at its periplasmic entrance by other components of the efflux complex.;tolC
